abstract |
The present invention relates to the diagnosis of breast cancer. It discloses the use of heterogeneous nuclear ribonucleoprotein K (hnRNP-K) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring hn RNP-K in said sample. Measurement of hnRNP-K can, e.g., be used in the early detection or diagnosis of breast cancer. |